In a U.S. national survey data, 57.6% of adults reported using at least one supplement, and use rose with age; among adults age 60 and older, nearly one quarter reported taking four or more supplements. At the same time, supplements are regulated differently from pharmaceutical medications; manufacturers are responsible for safety and labeling before sale, but most products are not reviewed by the FDA for safety before they reach the market. That combination widespread use, frequent polypharmacy, and lighter premarket oversight is exactly why professional review matters.
The core reason to involve a healthcare provider that is well versed in supplements is not that supplements are always dangerous. It is that their benefits and risks depend heavily on the person, the dose, the product, the diagnosis, and the medication list. Some risks are obvious, such as bleeding with antithrombotic drugs or serotonin toxicity with serotonergic combinations. Others are quieter: a supplement can lower the blood level of a prescription medicine, distort lab results, worsen a chronic condition, or gradually deplete another nutrient. Healthcare professionals help sort out when a supplement is appropriate, whether the dose makes sense, how to choose a better-quality product, and what monitoring is needed.
The practical takeaway is simple: supplements should be treated as biologically active products, not harmless accessories. Before purchasing one, talk to your healthcare provider. If you are pregnant, older, have kidney or liver disease, use anticoagulants, are preparing for surgery, or have complex chronic illness, this step is even more important.
Introduction
Supplement use is now part of ordinary health behaviour for many people. National Center for Health Statistics data show that more than half of U.S. adults use supplements, women report higher use than men, and use increases substantially with age. This means that supplements are often being layered on top of prescription medicines, over-the-counter products, and chronic disease management rather than used in isolation.
Why professional oversight matters
Professional oversight matters first because supplements can be the wrong answer to the wrong problem. Fatigue, hair loss, cramps, anxiety, insomnia, low mood, palpitations, tingling, brain fog, or gastrointestinal symptoms can come from iron deficiency, thyroid disease, diabetes, sleep apnea, depression, cardiac disease, medication adverse effects, pregnancy, or malignancy. A supplement started before proper evaluation can delay diagnosis or make interpretation harder. NCCIH advises people to discuss complementary health products with healthcare providers specifically to review safety, effectiveness, and interactions.
It also matters because dose is often where risk begins. The tolerable upper intake level for magnesium from supplements is 350 mg/day, primarily due to gastrointestinal side effects such as diarrhea, although higher doses are commonly used under clinical supervision. For zinc, the adult tolerable upper intake level is 40 mg/day; doses of 50 mg or more for weeks can interfere with copper absorption, reduce immune function, and lower HDL cholesterol. These are not exotic toxicology scenarios, they are common “wellness aisle” dosing errors.
Quality oversight matters too. FDA continues to warn about products sold as supplements that contain undeclared active substances, and the agency explicitly notes that its fraud database represents only a small fraction of potentially hazardous products. In other words, the label may be incomplete or misleading. Many retail and online vendors sell supplements marketed for weight loss, muscle growth, and general wellness but are those ingredients well researched, from a clean source, and safe to use? These questions can be answered by healthcare professionals.
Finally, some groups should almost never self-prescribe supplements casually. These include pregnant people, children, older adults with polypharmacy, people with kidney or liver disease, people on anticoagulants, and anyone heading into surgery or a procedure. Not all supplements are safe during pregnancy just like not all pharmaceutical drugs are safe during pregnancy and should be used with caution and under the care of a healthcare provider. The reason is straightforward: the same capsule can be reasonable for one person and risky for another.
Common Supplement and Drug interaction
|
Supplement or food |
Example medications |
Main mechanism |
Potential clinical consequence |
Practical management |
Key evidence |
|
St. John’s wort |
SSRIs, SNRIs, triptans, other serotonergic drugs |
Additive serotonergic effects; St. John’s wort can also affect drug metabolism broadly |
Serotonin toxicity, with agitation, diarrhea, tachycardia, hypertension, hallucinations, hyperthermia, and other symptoms that can appear within hours |
Avoid self-combining. Seek urgent care for serotonin symptoms. Do not use it to self-treat depression instead of obtaining care. |
NCCIH and Medsafe both warn about serious serotonergic reactions. |
|
St. John’s wort |
Warfarin |
Induction of CYP enzymes, especially CYP3A4 and CYP2C9, reducing warfarin exposure/effect |
Lower INR and loss of anticoagulant effect, increasing thrombosis risk |
Do not start or stop without clinician input; check INR closely if exposure changes. |
Medsafe specifically advises checking INR and stopping St. John’s wort with monitoring because INR can rise after withdrawal. |
|
St. John’s wort |
Cyclosporine, tacrolimus, digoxin, oral contraceptives, some HIV drugs, some cancer drugs, some statins |
Enzyme and transporter induction lowers blood concentrations of many drugs |
Transplant rejection, treatment failure, breakthrough bleeding, loss of rhythm control, reduced statin effect |
Usually avoid unless the treating clinician specifically approves and monitors. |
NCCIH lists warfarin, cyclosporine, digoxin, HIV drugs, cancer drugs, oral contraceptives, and certain statins among key interactions. |
|
Grapefruit |
Simvastatin, atorvastatin, other susceptible CYP3A4 drugs |
Inhibits intestinal CYP3A4; sometimes affects transporters |
Higher blood levels of the drug, increasing adverse effects. With statins, risk includes muscle injury and liver toxicity |
Check the exact drug label or medication guide. Avoid grapefruit when warned, or ask about a non-affected alternative. |
FDA explains that grapefruit can let “more of the drug enter the blood” by blocking intestinal CYP3A4. |
|
Ginkgo biloba |
Warfarin, DOACs, aspirin, clopidogrel, NSAIDs |
May increase bleeding susceptibility; possible antiplatelet effects; may also influence some drug transport/metabolism pathways |
Bruising, GI bleeding, perioperative bleeding, hemorrhage risk in susceptible patients |
If used at all, do so only after clinician review; EMA advises stopping 3–4 days before surgery and monitoring when starting or stopping around warfarin. |
NCCIH warns of bleeding risk with anticoagulants; EMA advises consultation and perioperative discontinuation. |
|
Fish oil or omega-3 supplements |
Warfarin, DOACs, aspirin, clopidogrel, NSAIDs |
Antiplatelet and antithrombotic effects may prolong bleeding time |
Theoretical or mild increased bleeding tendency; however, recent pooled clinical data do not show a general increase in clinically significant bleeding, except possible modest risk with high-dose purified EPA |
Do not assume “natural” means interaction-free. Discuss dose, reason for use, other antithrombotics, and procedures with a clinician. |
NCCIH advises caution with clotting-active drugs; a 2024 meta-analysis found no overall bleeding increase, though high-dose purified EPA may add risk. |
|
Calcium, iron, or magnesium supplements |
Levothyroxine |
Binding or chelation in the gut reduces absorption of levothyroxine |
Under-treatment of hypothyroidism, unstable TSH, persistent symptoms |
Separate levothyroxine from calcium by at least 4 hours; apply the same caution to other mineral supplements unless a clinician advises otherwise. |
NHS and pharmacokinetic studies show calcium impairs levothyroxine absorption. |
|
Calcium, iron, magnesium, zinc, aluminum |
Tetracycline and fluoroquinolone antibiotics |
Chelation markedly lowers antibiotic absorption |
Reduced antibiotic bioavailability and potential treatment failure |
Space doses carefully or avoid concomitant use according to prescribing advice. |
Reviews and NHS prescribing guidance support this interaction. |
St. John’s wort is one of the clearest examples of why “herbal” does not mean benign. NCCIH states plainly that it can interact in dangerous, sometimes life-threatening ways with many medicines. It is particularly problematic because it can both raise serotonin-related toxicity with some combinations and lower the effectiveness of many critical drugs by inducing metabolism and transport. Just as important, when St. John’s wort is stopped, blood levels of the interacting drug may rise again over the next several days, so abrupt unsupervised discontinuation can also create problems.
Grapefruit is not a supplement, but it belongs in any serious conversation about “natural” interactions. FDA explains that for many susceptible drugs, grapefruit blocks intestinal CYP3A4 so that more drug enters the bloodstream and stays there longer. With some statins, that can translate into more muscle and liver toxicity. The clinical lesson is not “never eat grapefruit” in general; it is “know whether your specific medicine is one of the susceptible ones.”
Ginkgo and fish oil require nuance. Ginkgo is widely treated as a bleeding-risk herb because of case reports, labeling precautions, and perioperative guidance. Fish oil is subtler: traditional caution is still reasonable, especially with anticoagulants or procedures, but the best recent pooled evidence does not support a broad claim that standard omega-3 supplementation causes major clinical bleeding in most patients. This is exactly the sort of nuance that gets lost when people rely on online “do not mix” lists instead of individualized review.
Supplements to avoid or review in specific conditions
Many of these supplements listed are not absolute, universal contraindications, but they are common situations where self-prescribing a supplement is poor risk management and clinician input is advisable.
|
Condition or population |
Supplement or product |
Why it can be risky |
Safer clinical approach |
Key evidence |
|
Pregnancy or trying to conceive |
High-dose preformed vitamin A |
Excess preformed vitamin A can cause fetal malformations, including abnormalities of the eyes, skull, lungs, and heart |
Use pregnancy-appropriate prenatal products and avoid high-dose retinol unless specifically prescribed |
ODS warns that too much preformed vitamin A in pregnancy can cause birth defects. |
|
HFE-related hemochromatosis or iron overload |
Iron supplements and high-dose vitamin C |
Iron adds to body iron stores; vitamin C enhances iron absorption and may worsen iron loading |
Avoid iron unless prescribed; discuss any vitamin C supplementation, especially when iron overloaded |
GeneReviews and EASL both advise avoiding iron supplements and limiting supplemental vitamin C. |
|
Chronic kidney disease |
Potassium supplements |
Reduced kidney function can impair potassium excretion, increasing the risk of hyperkalemia and arrhythmia |
Use only if prescribed and monitored with kidney function and potassium levels |
NHS CKD guidance specifically advises avoiding potassium supplements because levels can become too high. |
|
Sarcoidosis and other granulomatous disorders |
Vitamin D and calcium supplements |
Sarcoid granulomas can increase active vitamin D production, predisposing to hypercalcemia and hypercalciuria |
Check calcium and vitamin D status before supplementing; monitor closely if supplementation is necessary |
Observational studies and reviews show increased hypercalcemia risk and emphasize pretesting/monitoring. |
|
Gallstones or biliary disease |
Peppermint oil |
EMA states peppermint oil medicines for minor belly problems must not be used in people with gallstones or other bile-related problems |
Use alternative GI symptom management after clinical review |
EMA public monograph lists gallstones and bile-related problems as contraindications or exclusion conditions. |
|
Liver disease or history of supplement-related liver injury |
Green tea extract |
Concentrated green tea extract has been implicated in clinically apparent acute liver injury, including acute liver failure |
Avoid concentrated extracts unless specifically advised; seek care urgently for jaundice, dark urine, or right-upper-quadrant pain |
NIH LiverTox documents acute liver injury associated with green tea extract. |
|
Hypertension, heart disease, or kidney disease |
Licorice root containing glycyrrhizin |
Glycyrrhizin can raise blood pressure, lower potassium, and trigger arrhythmias; vulnerable patients may react even at relatively modest exposures |
Avoid glycyrrhizin-containing products unless a clinician says otherwise |
NCCIH notes severe effects including irregular heartbeat and cardiac arrest, with greater risk in people with hypertension or heart/kidney disease. |
|
Bipolar disorder |
SAMe |
SAMe may worsen manic symptoms |
Do not self-treat depressive symptoms with SAMe in bipolar disorder without psychiatric supervision |
NCCIH states SAMe may not be safe for bipolar disorder and may worsen mania. |
|
Autoimmune thyroid disease, hyperthyroidism, hypothyroidism, or preparation for radioactive iodine therapy |
Kelp or high-iodine supplements |
Excess iodine can worsen thyroid dysfunction in susceptible people; thyroid-cancer patients preparing for radioactive iodine are often told to follow a low-iodine diet |
Avoid unsupervised iodine/kelp supplements; discuss use with the thyroid team |
ODS notes iodine concentration in the thyroid and low-iodine diets before radioiodine; excess iodine is associated with thyroid dysfunction and autoimmunity. |
|
Hormone-sensitive cancer or tamoxifen therapy |
DHEA |
DHEA is a hormone precursor that may worsen hormone-sensitive cancers; MSKCC notes possible tamoxifen resistance |
Avoid unless the oncology team specifically approves |
Mayo advises avoiding DHEA in hormone-sensitive cancer, and MSKCC warns against combining it with tamoxifen. |
Supplements and products that can lower nutrient status. Some products are taken to improve health but can quietly lower another nutrient, block its absorption, or make a deficiency more likely over time. This is another reason self-directed “stacking” is risky: the person may end up taking a second supplement to fix a problem caused by the first.
|
Product |
Nutrient affected |
What happens |
Mitigation |
|
High-dose zinc |
Copper |
Zinc interferes with copper absorption; excessive zinc use can lead to copper deficiency |
Avoid chronic high-dose zinc unless there is a documented reason; consider copper monitoring if prolonged high-dose zinc is necessary. |
|
Very high-dose zinc |
Magnesium |
Very high supplemental zinc can also reduce magnesium absorption |
Keep zinc within evidence-based dosing and monitor if high doses are used for weeks to months. |
|
Iron supplements taken with zinc |
Zinc |
Supplements containing 25 mg elemental iron or more can reduce zinc absorption when taken at the same time |
Separate dosing times if both are medically needed. |
|
Calcium supplements |
Iron |
Calcium has a statistically significant short-term inhibitory effect on iron absorption, although the overall long-term effect on hemoglobin is less clear in many people |
If iron deficiency is present or suspected, separate calcium and iron dosing and individualize timing. |
|
Fibre supplements |
Concurrent drugs and possibly some concurrently taken nutrients |
Fibre can carry medications through the gut before full absorption; fibre intake also influences nutrient absorption mechanisms more broadly |
Take medications 2–3 hours before or after fibre supplements unless instructed otherwise. |
|
Activated charcoal |
Drugs, vitamins, minerals, antioxidants, and some fat-soluble nutrients |
Activated charcoal may interfere with absorption of medications and nutrients when used repeatedly. |
Do not use charcoal casually as a daily “detox” product; avoid routine ingestion unless a clinician recommends it. |
|
Proton-pump inhibitors |
Vitamin B12, and possibly iron and calcium in some patients |
Acid suppression interferes with release of food-bound vitamin B12 from proteins and may lead to deficiency over time |
In long-term users, review B12 status when symptoms or risk factors are present; free B12 in supplements is usually absorbed better than food-bound B12 in people with food-release problems. |
The most clinically important example here is probably high-dose zinc causing copper deficiency. People often start zinc for “immunity,” acne, colds, or wound healing, then stay on it for months. ODS notes that even moderately high zinc intakes of about 60 mg/day for up to 10 weeks can reduce copper status. That can eventually contribute to anemia, neurologic symptoms, and immune dysfunction.
The PPI–vitamin B12 example shows that not every nutrient problem comes from a supplement bottle. ODS explains that PPIs can interfere with vitamin B12 absorption from food by slowing gastric acid release, and JAMA studies have found a significant association between long-term acid suppression and vitamin B12 deficiency. This matters because many people with reflux also self-prescribe supplements, creating overlapping regimens. If long-term acid suppression is necessary, the question is not “panic and stop the PPI”; it is “monitor intelligently for deficiency and treat it appropriately if it appears.”
When you talk to a healthcare professional, bring the actual product or clear photos of it: front label, Supplement Facts panel, ingredient list, dose per serving, and the exact amount you take. Also bring your prescription medicines, over-the-counter drugs, “as needed” products, tea powders, energy products, gummies, protein powders, and anything you take only occasionally. Even NHS surgical guidance tells patients to bring a complete list of medicines, vitamins, and herbal supplements, because what seems minor to the patient may matter clinically.
Conclusion
Supplements can be useful but they are also biologically active exposures. That means they deserve the same habits of clinical thinking we would apply to any active therapy: clear indication, appropriate dose, patient selection, interaction screening, contraindication review, product-quality scrutiny, monitoring, and follow-up. This article is meant to be informative. Often, patients encounter popular supplements on social media and believe that it will be effective for them too. The natural products that are being promoted online may not have clean ingredients or may interact with medications that you are taking. To be safe, it is always recommended to speak to your healthcare professionals first.
